Synonyms:
Status: Phase 2
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: 1W7BD1M08N

Pharmacology

Action Mechanism of Action Reference
ANTAGONIST Epidermal growth factor receptor erbB1 antagonist

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Neoplasms 1 D009369 ClinicalTrials

Cross References

Resources Reference
CAS NUMBER 1310460-86-6
ChEMBL CHEMBL3989988
FDA SRS 1W7BD1M08N